CADL · Candel Therapeutics, Inc.
Market Cap
$1.00B
Shares
76.52M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-12 | Canaccord Genuity’s 46th Annual Growth Conference | Conference |
| 2026-06-03 | 2026 Jefferies Global Healthcare Conference (New York, NY) | Conference |
| 2026-05-20 | Stifel 2026 Virtual Targeted Oncology Forum | Event |
| 2026-05-15 | AUA Annual Meeting - Candel Therapeutics Call | Shareholder meeting |
| 2026-03-03 | TD Cowen 46th Annual Health Care Conference | Conference |
| 2025-12-05 | Candel Therapeutics to Host Virtual R&D Event | Event |
| 2025-11-18 | Jefferies Global Healthcare Conference in London | Conference |
| 2025-08-13 | CG 45th Annual Growth Conference | Conference |
| 2025-06-05 | Jefferies Global Healthcare Conference | Conference |
| 2025-06-03 | Candel Therapeutics’ Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation | Conference |
| 2025-05-14 | Bank of America Securities 2025 Health Care Conference | Conference |
Source: https://ir.candeltx.com/
Key facts
CIK
1841387
CUSIP
137404109
13F (30d)
116 filings
116 filers
Visit website
Investor relations